Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 14Myeloid 3Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Lymphoma 160Leukemia 109Burkitt Lymphoma 92Lymphoma, Non-Hodgkin 85Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Mantle-Cell 70Leukemia, Myeloid, Acute 53Lymphoma, Follicular 49Hodgkin Disease 44Lymphoma, Large-Cell, Immunoblastic 37Leukemia, Lymphocytic, Chronic, B-Cell 33Recurrence 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29Leukemia, Biphenotypic, Acute 25Lymphoma, B-Cell, Marginal Zone 24Myelodysplastic Syndromes 23Blast Crisis 19Lymphoma, Large-Cell, Anaplastic 18Lymphoma, B-Cell 18Dendritic Cell Sarcoma, Interdigitating 17Congenital Abnormalities 17Leukemia, Myeloid, Accelerated Phase 16Leukemia, Myelomonocytic, Chronic 15Multiple Myeloma 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, T-Cell 11Myeloproliferative Disorders 10Anemia, Refractory, with Excess of Blasts 10Neoplasms, Plasma Cell 9

Interventions

fludarabine 7Tacrolimus 6fludarabine phosphate 5Whole-Body Irradiation 5Cyclophosphamide 5Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Methotrexate 4Sirolimus 3Melphalan 3Cytarabine 3Bone Marrow Transplantation 3thymoglobulin 2ponatinib 2Patient Reported Outcome Measures 2Mesna 2Behavior Therapy 2quizartinib 1nicotinamide-beta-riboside 1methanesulfonic acid 1etoposide phosphate 1blinatumomab 1Thiotepa 1Stem Cell Transplantation 1Social Determinants of Health 1RFT5-SMPT-dgA immunotoxin 1Photopheresis 1Panobinostat 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Leukemia, Myeloid × Cytarabine × Lymphoid × Clear all
NCT01411267 2022-04-04

AC220 for Children With Relapsed/Refractory ALL or AML

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Completed
24 enrolled 14 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01861002 2021-06-09

A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Completed
15 enrolled 10 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01321346 2015-11-24

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Leukemia, Myeloid, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡